Carlos Sariol 0 0 Active/Enrolling June 19, 2019 ELI LILLY (I4V-MC-JAJA) A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid ArthritisRead More
Carlos Sariol 0 0 Active/Enrolling June 19, 2019 ELI LILLY (I8F-MC-GPGH) A Randomized, Phase 3, Open-Label Trial Comparing the effect of LY3298176 versus Titrated Insulin Degludec…Read More
Carlos Sariol 0 0 Active/Enrolling June 19, 2019 INTERCEPT PHARMACEUTICALS, INC. (747-304) A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of…Read More